Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.25 USD | +2.72% | -1.30% | +2.22% |
05-08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
05-08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.22% | 1.84B | |
+25.97% | 49.18B | |
+0.82% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+12.52% | 26.09B | |
-21.90% | 18.71B | |
+9.06% | 13.26B | |
+31.51% | 12.32B | |
-0.31% | 11.99B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- HC Wainwright Adjusts Syndax Pharmaceuticals Price Target to $42 From $38, Maintains Buy Rating